Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Res Rep Urol ; 14: 7-15, 2022.
Article in English | MEDLINE | ID: mdl-35079597

ABSTRACT

INTRODUCTION: The aim of this study was to analyze urinalysis findings and urinary bacterial culture in hemodialysis-dependent end-stage renal disease patients. The research goal was to understand the proportion, risk factors, and the causative organisms of urinary tract infection in hemodialysis-dependent end-stage renal disease patients. MATERIALS AND METHODS: Between May 2020 and June 2021, this study included 100 hemodialysis-dependent end-stage renal disease patients (50 male patients and 50 female patients). The urine underwent microscopic examination, pyuria was defined as ≥5 white blood cells per high-power field, and urinary bacterial cultures were conducted for patients with pyuria. Bacteriuria was defined as ≥104 colony-forming units/mL in men and ≥105 colony-forming units/mL in women. Daily urine output was investigated by oral listening. Postvoiding residual urine volume was measured. RESULTS: Fifty-six percent of male patients and 30% of female patients had normosthenuria, 24% of male patients and 38% of female patients had pyuria, and 20% of male patients and 32% of female patients had a urinary tract infection. A comparison of normosthenuria and urinary tract infection revealed no statistically significant difference in age, time on dialysis, daily urine output, and postvoiding residual urine volume. The proportion of female patients among those with normosthenuria was 34.8%, whereas the proportion of female patients among those with UTI was 61.5%. Urinary bacterial cultures showed that the major causative organisms were Escherichia coli (45%; 18/40 cultures) and extended spectrum beta-lactamase-producing Escherichia coli (17.5%; 7/40 cultures). CONCLUSION: The incidence of urinary tract infection was higher in female patients than in male patients. The proportion of resistant bacteria as the causative organisms was high in hemodialysis-dependent end-stage renal disease patients. Urinary bacterial culture should be checked while patients are able to void urine.

2.
Gan To Kagaku Ryoho ; 43(1): 133-6, 2016 Jan.
Article in Japanese | MEDLINE | ID: mdl-26809542

ABSTRACT

A 71-year-old male patient began FOLFOX6 plus panitumumab treatment for unresectable recurrent rectal cancer. He developed thrombocytopenia after 2 courses of treatment and therefore a platelet transfusion was performed. The day after transfusion, the patient developed jaundice and hematuria. His lactate dehydrogenase levels had increased and a peripheral blood smear review revealed the presence of schistocytes. Anti-ADAMTS13 antibodies were present, and there was a reduction in ADAMTS13 activity. The patient was diagnosed with thrombotic thrombocytopenic purpura and treated with a plasma exchange. The day after the plasma exchange, his clinical condition rapidly worsened and he died. Thrombocytopenia due to chemotherapy often appears as myelosuppression. If conditions such as jaundice, indirect bilirubinemia, or hematuria appear during the course of chemotherapy, this condition must be considered as a differential diagnosis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Purpura, Thrombotic Thrombocytopenic/complications , Rectal Neoplasms/drug therapy , ADAM Proteins/metabolism , ADAMTS13 Protein , Aged , Antibodies, Monoclonal/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Disease Progression , Fatal Outcome , Fluorouracil/administration & dosage , Humans , Leucovorin/administration & dosage , Male , Organoplatinum Compounds/administration & dosage , Panitumumab , Plasma Exchange , Purpura, Thrombotic Thrombocytopenic/enzymology , Purpura, Thrombotic Thrombocytopenic/therapy , Rectal Neoplasms/complications , Rectal Neoplasms/pathology , Recurrence
3.
Histol Histopathol ; 28(3): 321-6, 2013 03.
Article in English | MEDLINE | ID: mdl-23348385

ABSTRACT

Neoplasms of the epididymis are uncommon, and malignant tumors are extremely rare. We report a case of clear cell papillary cystadenocarcinoma of the epididymis presenting with a long history of painless scrotal mass on the left side. Immunohistochemical markers for clear cell renal cell carcinoma (RCC) were examined to distinguish between clear cell papillary cystadenocarcinoma of the epididymis and metastatic clear cell renal cell carcinoma. The present case was positive for cytokeratin-7, PAX2, vinculin, vimentin and carbonic anhydrase IX. Expression of CD10 was focally observed. In contrast, no immunoreactivities for α-methylacyl-CoA racemase, RCC marker, glutathione S-transferase α or C-KIT were detected. The immunophenotypic profile of clear cell papillary cystadenocarcinoma of the epididymis closely resembles that of clear cell papillary RCC, although the immunohistochemical markers tested in this study are useful to make a differential diagnosis between clear cell papillary cystadenocarcinoma of the epididymis and metastatic clear cell RCC.


Subject(s)
Adenocarcinoma, Clear Cell/diagnosis , Carcinoma, Renal Cell/diagnosis , Cystadenocarcinoma, Papillary/diagnosis , Epididymis/pathology , Testicular Neoplasms/diagnosis , Adenocarcinoma, Clear Cell/metabolism , Adenocarcinoma, Clear Cell/surgery , Aged , Biomarkers, Tumor/metabolism , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/secondary , Cystadenocarcinoma, Papillary/metabolism , Cystadenocarcinoma, Papillary/surgery , Diagnosis, Differential , Epididymis/metabolism , Humans , Male , Orchiectomy , Testicular Neoplasms/metabolism , Testicular Neoplasms/surgery
4.
J Urol ; 185(6): 2353-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21511296

ABSTRACT

PURPOSE: Renal cell carcinoma is a typical hypervascular tumor in which neovascularization may have a large part in progression. We examined expression of the cancer regulating, p53 targeted angiogenesis inhibitor brain-specific angiogenesis inhibitor 1 in renal cell carcinoma tissue to elucidate the clinical significance of its expression. MATERIALS AND METHODS: We examined brain-specific angiogenesis inhibitor 1 mRNA and protein expression in 47 renal cell carcinoma and 10 normal kidney tissues using real-time quantitative polymerase chain reaction and immunohistochemistry, respectively. Levels of VEGF and bFGF mRNA, and immunohistochemical expression of p53 protein were also investigated in the same renal cell carcinoma tissues. RESULTS: A significant decrease in BAI1 mRNA was noted in renal cell carcinoma tissue compared with that in normal kidney tissue (p <0.001). Immunostaining for brain-specific angiogenesis inhibitor 1 was also decreased in carcinoma tissue compared with normal kidney tissue. BAI1 mRNA and protein expression were lower in advanced renal cell carcinoma (pT3-4) than in localized renal cell carcinoma (pT1-2) tissues (p <0.03 and 0.003, respectively). A significant negative correlation was observed between microvessel density and brain-specific angiogenesis inhibitor 1 protein expression (r = -0.4056, p = 0.002). No significant correlation was noted between BAI1 and VEGF or bFGF mRNA levels. Brain-specific angiogenesis inhibitor 1 protein expression did not correlate with p53 protein expression. CONCLUSIONS: These observations suggest that down-regulation of brain-specific angiogenesis inhibitor 1 expression may be a critical factor in renal cell carcinoma development and BAI1 may be a promising candidate for gene therapy of renal cell carcinoma.


Subject(s)
Angiogenic Proteins/biosynthesis , Carcinoma, Renal Cell/blood supply , Carcinoma, Renal Cell/metabolism , Kidney Neoplasms/blood supply , Kidney Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Neovascularization, Pathologic , Receptors, G-Protein-Coupled
5.
J Epidemiol ; 20(1): 30-9, 2010.
Article in English | MEDLINE | ID: mdl-19881229

ABSTRACT

BACKGROUND: Many studies have estimated the prevalence of anti-hepatitis C virus (HCV) antibody among hemodialysis (HD) patients; however, the prevalence of HCV core antigen-which indicates the presence of chronic HCV infection-is not known. METHODS: Standardized prevalence ratios (SPRs) for anti-HCV antibody and HCV core antigen among HD patients (n = 1214) were calculated on the basis of data from the general population (n = 22 472) living in the same area. RESULTS: The prevalences of anti-HCV antibody and HCV core antigen were 12.5% and 7.8%, respectively, in male hemodialysis patients, and 8.5% and 4.1% in female hemodialysis patients. The SPRs (95% confidence interval) for anti-HCV antibody and HCV core antigen were 8.39 (6.72-10.1) and 12.9 (9.66-16.1), respectively, in males, and 5.42 (3.67-7.17) and 8.77 (4.72-12.8) in females. CONCLUSIONS: The prevalences of chronic HCV infection among male and female HD patients were 13-fold and 9-fold, respectively, those of the population-based controls. Further studies should therefore be conducted to determine the extent of chronic HCV infection among HD patients in other populations and to determine whether chronic HCV infection contributes to increased mortality in HD patients.


Subject(s)
Hepacivirus/immunology , Hepatitis C Antibodies/blood , Hepatitis C Antigens/blood , Hepatitis C, Chronic/epidemiology , Renal Dialysis/adverse effects , Adult , Age Factors , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/transmission , Humans , Japan/epidemiology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Prospective Studies , Risk Factors , Seroepidemiologic Studies , Sex Factors , Young Adult
6.
Oncol Lett ; 1(4): 697-701, 2010 Jul.
Article in English | MEDLINE | ID: mdl-22966366

ABSTRACT

This study investigated the expression of hypoxia-inducible protein 2 (HIG2), a novel renal cell carcinoma (RCC)-associated molecule and an essential growth factor for RCC, in kidneys to elucidate its clinical significance in RCC. An immunohistochemical study of HIG2 was conducted in 93 surgical samples of RCC tissues and 10 samples of normal kidney tissues obtained after nephrectomies for localized RCC. HIG2 expression was also correlated with clinicopathological characteristics and survival. Only faint or weak immunostaining for HIG2 was observed in normal kidney samples. HIG2 expression was found in 86% of RCC tissues (80/93). When analyzed by histological type, positive staining for HIG2 was detected in all papillary (7/7), chromophobe (1/1) and cyst-associated (3/3) RCC. In contrast, the HIG2 expression was observed in 85% of clear cell (68/80) and 50% of spindle cell (1/2) RCC. Labeling indices were 74.1, 45.4, 39, 24.8 and 12.1% in papillary, spindle, clear cell, cyst-associated and chromophobe RCC, respectively. A significant increase in HIG2 expression was noted in RCC tissues obtained from patients with high stage RCC, lymph node metastasis and high nuclear grade (p<0.001, p<0.02 and p<0.006, respectively). RCC patients with a negative HIG2 staining had prolonged 5-year cancer-specific survival. In conclusion, HIG2 expression was extensively observed in RCC tissues and was higher in advanced RCC, suggesting that HIG2 is a candidate for the development of molecular targeting therapy.

7.
J Urol ; 180(2): 481-5, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18550099

ABSTRACT

PURPOSE: We examined hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor-kappaB in acquired cystic disease of the kidney associated with renal cell carcinoma to elucidate the roles of these factors in cyst formation and subsequent tumor transformation. MATERIALS AND METHODS: Immunohistochemical expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and phosphorylated nuclear factor-kappaB (active form) were examined in 20 normal kidney samples obtained from nephrectomy for localized renal cell carcinoma and 25 kidneys with acquired cystic disease associated renal cell carcinoma from 23 patients on dialysis. RESULTS: Only faint or weak immunostaining for hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and phosphorylated nuclear factor-kappaB was observed in normal kidney tissues. In nontumor areas of the kidneys with acquired cystic disease expressions of these 3 proteins was up-regulated in tubular and cyst epithelial cells. Acquired cysts were classified into 3 types according to cyst epithelium morphology, namely flat, cuboidal and hyperplastic. Hyperplastic cysts were the predominant cysts expressing hypoxia-inducible protein 2 and hypoxia-inducible factor-1alpha. Although up-regulation of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and phosphorylated nuclear factor-kappaB was observed in renal cell carcinoma, positive hypoxia-inducible protein 2 immunostaining was detected predominantly in papillary renal cell carcinoma, while positive hypoxia-inducible factor-1alpha and phosphorylated nuclear factor-kappaB immunostaining was prominent in clear cell renal cell carcinoma. CONCLUSIONS: Hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and phosphorylated nuclear factor-kappaB may be involved in a continuous process of the evolution of phenotypic expression from a simple cyst to epithelial hyperplasia and eventually to tumor.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Renal Cell/metabolism , Cell Transformation, Neoplastic/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Kidney Diseases, Cystic/metabolism , Kidney Failure, Chronic/metabolism , Kidney Neoplasms/metabolism , Adult , Aged , Biomarkers, Tumor/genetics , Biopsy, Needle , Carcinoma, Renal Cell/pathology , Cell Transformation, Neoplastic/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Immunohistochemistry , Kidney Diseases, Cystic/pathology , Kidney Diseases, Cystic/surgery , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/therapy , Kidney Neoplasms/pathology , Male , Middle Aged , NF-kappa B/genetics , Nephrectomy , Probability , Prognosis , Risk Assessment , Sensitivity and Specificity , Statistics, Nonparametric , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
8.
Oncol Rep ; 18(4): 785-91, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17786337

ABSTRACT

This study was designed to elucidate the therapeutic effect of transfering the brain-specific angiogenesis inhibitor 1 (BAI1) gene to a mouse renal cell carcinoma cell line (Renca). Female BALB/c mice were inoculated subcutaneously with wild-type Renca (Renca/Wild) cells or Renca cells transfected with the BAI-1 (Renca/BAI-1) or LacZ (Renca/LacZ) gene. Tumor growth was observed every other day from 3 to 35 days after implantation. Moreover, the intratumoral injection of the adenovirus vector containing the gene encoding BAI1 was conducted at two-day intervals from 11 to 31 days after implantation of the Renca/Wild or Renca/BAI1 tumor. Tumor blood flow was measured by colorimetric angiogenesis assay (CAA). The concentration of the vascular endothelial growth factor (VEGF) in the cell culture supernatants was determined by enzyme-linked immunoassay. The size of the Renca/BAI1 tumor was significantly (p<0.01) suppressed compared to the Renca/Wild and Renca/LacZ tumors 21 days after tumor implantation. The injection of the BAI1 viral vector at 2-day intervals significantly inhibited the growth of both the Renca/Wild and Renca/BAI1 tumors. The blood volume measured by CAA and microvessel density was significantly lower in the Renca/BAI1 than in the Renca/Wild and Renca/LacZ tumors (p<0.01 and p<0.05, respectively). A significant (p<0.01) reduction in VEGF concentration in the supernatant was demonstrated in the Renca/BAI1 compared with the Renca/Wild and Renca/LacZ cell cultures. These observations suggest that the transfer of the BAI1 gene to Renca can suppress the tumor growth via the inhibition of angiogenesis. The down-regulation of VEGF production in tumor cells contributes to this anti-tumor effect.


Subject(s)
Angiogenic Proteins/genetics , Carcinoma, Renal Cell/blood supply , DNA, Complementary/metabolism , Gene Transfer Techniques , Genetic Therapy , Kidney Neoplasms/blood supply , Neovascularization, Pathologic/prevention & control , Animals , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/pathology , Enzyme-Linked Immunosorbent Assay , Female , Kidney Neoplasms/metabolism , Kidney Neoplasms/pathology , Mice , Mice, Inbred BALB C , Receptors, G-Protein-Coupled , Tumor Cells, Cultured , Vascular Endothelial Growth Factor A/metabolism , Xenograft Model Antitumor Assays
9.
J Urol ; 178(4 Pt 1): 1497-503, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17707062

ABSTRACT

PURPOSE: The active form of vitamin D3, that is 1alpha,25-dihydroxyvitamin D3, binds with vitamin D receptor, which forms a complex with retinoid X receptors alpha, beta and gamma to manifest antitumor effects. We examined the expression of vitamin D receptor and retinoid X receptors in renal cell carcinoma and elucidated the prognostic significance of these receptors. MATERIALS AND METHODS: We performed immunohistochemical examination of vitamin D receptor, and retinoid X receptors alpha, beta and gamma in nephrectomized specimens of 68 patients with renal cell carcinoma. We analyzed the correlation between the expression of these receptors and clinicopathological parameters or patient survival. Mean followup was 68.2 months. RESULTS: No significant correlation was found between the expression of vitamin D receptor, retinoid X receptor alpha or beta and clinicopathological parameters. In contrast, retinoid X receptor gamma expression correlated significantly with tumor stage (p = 0.009) and distant metastasis (p = 0.005). The 5-year cancer specific survival rate was higher in patients with retinoid X receptor gamma positive renal cell carcinoma than those with retinoid X receptor gamma negative renal cell carcinoma (79.3% vs 40.0%, p <0.05). Cox regression analysis revealed that retinoid X receptor gamma expression, tumor status and lymph node status were significant independent prognostic factors in patients with renal cell carcinoma (p <0.05). A significant correlation was observed between the expression of retinoid X receptor gamma and tumor stage, distant metastasis or the 5-year cancer specific survival rate. Furthermore, retinoid X receptor gamma expression was an independent prognostic factor in patients with renal cell carcinoma. CONCLUSIONS: Our observations suggest that alterations of vitamin D receptor and retinoid X receptor expression may be involved in renal carcinogenesis and retinoid X receptor gamma expression may be a useful prognostic marker in patients with renal cell carcinoma.


Subject(s)
Carcinoma, Renal Cell/genetics , Kidney Neoplasms/genetics , Receptors, Calcitriol/genetics , Retinoid X Receptor gamma/genetics , Adult , Aged , Aged, 80 and over , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/pathology , Female , Gene Expression/physiology , Humans , Kidney/pathology , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Retinoid X Receptor alpha/genetics , Retinoid X Receptor beta/genetics , Statistics as Topic , Survival Rate
10.
Int J Urol ; 14(6): 483-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17593089

ABSTRACT

AIM: Biological and epidemiologic data suggest that 1 alpha, 25 dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) levels may influence development of renal cell carcinoma. The vitamin D receptor (VDR) is a crucial mediator for the cellular effects of 1,25(OH)(2)D(3) and additionally interacts with other cell signaling pathways that influence cancer progression. VDR gene polymorphisms may play an important role in risk of incidence for various malignant tumors. This study investigated whether VDR gene polymorphisms were associated with increased risk and prognosis of renal cell carcinoma (RCC) in a Japanese population. METHODS: To analyze risk of RCC depending on VDR polymorphism, a case-control association study was performed. The VDR gene polymorphisms at three locations, BsmI, ApaI and TaqI, were genotyped in 135 RCC patients and 150 controls in a Japanese population. Logistic regression models were used to assess the genetic effects on prognosis. RESULTS: Significant differences in the ApaI genotype were observed between RCC patients and controls (chi(2) = 6.90, P = 0.032). No statistical significant difference was found in the BsmI and TaqI polymorphisms. The frequency of the AA genotype in the ApaI polymorphism was significantly higher in the RCC patients than in the controls (odds ratio, 2.59; 95% confidence intervals, 1.21-5.55; P = 0.012). Multivariate regression analysis showed that the AA genotype was an independent prognostic factor for cause-specific survival (relative risk 3.3; P = 0.038). CONCLUSION: The AA genotype at the ApaI site of the VDR gene may be a risk of incidence and poor prognosis factor for RCC in the Japanese population. Additional studies with a large sample size and investigation of the functional significance of the ApaI polymorphism in RCC cells are warranted.


Subject(s)
Carcinoma, Renal Cell/genetics , Carcinoma, Renal Cell/mortality , Kidney Neoplasms/genetics , Kidney Neoplasms/mortality , Receptors, Calcitriol/genetics , Adult , Aged , Aged, 80 and over , Carcinoma, Renal Cell/pathology , Disease Progression , Female , Gene Frequency , Genetic Predisposition to Disease/epidemiology , Genotype , Humans , Japan/epidemiology , Kidney Neoplasms/pathology , Male , Middle Aged , Polymorphism, Genetic , Prognosis , Risk Factors , Survival Analysis
11.
Int J Urol ; 13(7): 987-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16882068

ABSTRACT

A 62-year-old man had a right renal mass incidentally diagnosed by ultrasonography. Magnetic resonance imaging revealed a well-defined right renal mass with homogenous low-signal intensity on the T(1)-weighted pulse sequence and heterogeneous high-signal intensity on the T(2)-weighted pulse sequence. A right nephrectomy was performed. The histological examination showed a myxoma, which is a very uncommon neoplasm in the kidney. Eight cases have been reported previously.


Subject(s)
Kidney Neoplasms/diagnosis , Myxoma/diagnosis , Diagnosis, Differential , Follow-Up Studies , Humans , Kidney Neoplasms/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Myxoma/surgery , Nephrectomy , Tomography, X-Ray Computed
12.
Jpn J Clin Oncol ; 36(7): 418-24, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16803843

ABSTRACT

BACKGROUND: We reviewed our experience with orthotopic continent urinary reconstruction after radical cystectomy to assess the feasibility of Studer ileal neobladder for patients who are relatively advanced in age. METHODS: Between June 1997 and January 2005, 31 consecutive male patients (mean age: 64 years) underwent lower urinary tract reconstruction after radical cystoprostatectomy. Perioperative and late complications, functional outcome of the neobladder, urinary continence, upper urinary tract status and renal function with the metabolic balance were evaluated in all patients. RESULTS: There was no perioperative death, and perioperative and late complication rates were 22.8% and 3.3%, respectively. All 31 patients were able to void urine. Although the mean maximal functional capacity of the neobladder was 122 ml at 1 month after surgery, the mean capacities were increased to 247 ml at 6 months and 321 ml at 1 year after the operation. Urodynamic results at 3 years showed unchanged characteristics as to micturition pattern and volume of residual urine and neobladder pressure remained low. Of 31 patients, 29 (93.5%) showed excellent or good continent status during the daytime and 9 (29%) were completely dry at night in 6 months after surgery. Even at 3 years after the operation, only 1 patient out of 21 evaluated required single pad during nighttime. In a subgroup of five patients (24%) older than 70 years, the status of continence was satisfactory at 3 years after the reconstruction, and only one patient required a pad during the night at that point. Renal function levels and metabolic status were comparable before surgery and 3 years after surgery. Moreover, pyelography revealed normal condition of the upper urinary tract 1 month postoperatively in almost all cases. CONCLUSIONS: These data provide evidence that Studer ileal neobladder is a satisfactory surgical technique for selected patients at our institute. Even for patients older than 70 years, this urinary diversion procedure is safe in terms of morbidity and efficacious as indicated by functional outcome.


Subject(s)
Urinary Diversion/methods , Urinary Reservoirs, Continent/physiology , Urination/physiology , Urodynamics , Age Factors , Aged , Cystectomy , Follow-Up Studies , Humans , Ileum/surgery , Male , Middle Aged , Quality of Life , Treatment Outcome , Urinary Bladder Neoplasms/surgery , Urinary Reservoirs, Continent/adverse effects
13.
Int J Urol ; 13(4): 395-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16734857

ABSTRACT

An anterior urethral valve with diverticulum is an uncommon cause of congenital urethral obstruction and urinary extravasation compared with a posterior urethral valve. We report a neonate presenting with an abdominal wall urinoma caused by rupture of an anterior urethral diverticulum. Urine drainage via urethral catheter was effective to resolve the abdominal urinoma. Voiding cystourethrogram performed 6 months after an endoscopic incision of the distal margin of the diverticulum revealed a normal urethra with smooth voiding. To our knowledge, no similar case has been reported previously.


Subject(s)
Abdominal Wall , Cysts/etiology , Diverticulum/complications , Urethral Diseases/complications , Cystoscopy , Cysts/diagnosis , Diverticulum/surgery , Follow-Up Studies , Humans , Infant, Newborn , Male , Rupture, Spontaneous , Urethral Diseases/surgery , Urine , Urography
14.
J Epidemiol ; 15(3): 96-105, 2005 May.
Article in English | MEDLINE | ID: mdl-15930806

ABSTRACT

BACKGROUND: The prevalence of cardiovascular risk factors and the prevalence of comorbidities in adult hemodialysis patients in Japan are not fully understood. METHODS: In "Kaleidoscopic Approaches to Patients with End-stage Renal Disease Study" (The KAREN Study, 2003), trained research stuff examined 1,214 adult hemodialysis patients (mean age, 61.2 years; 779 males and 435 females) of 1,506 patients in northern areas of Iwate Prefecture. Cardiovascular risk factors and the prevalence of comorbidities in hemodialysis patients were compared with those in the general population using direct age-adjustment methodology and standardized morbidity ratios (SMRs). RESULTS: In hemodialysis patients, common causes of end-stage renal disease were chronic glomerulonephritis (29.8%), diabetic nephropathy (24.5%), and other diseases. Prevalence and SMR of myocardial infarction were 5% and 9.6, respectively, and those of stroke were 13% and 5.7. The prevalences of hypertension and diabetes mellitus were 87% and 29%, respectively. Mean systolic blood pressure and mean diastolic blood pressure were 155 mmHg and 85 mmHg, respectively. Mean levels of total serum cholesterol, high-density lipoprotein cholesterol, and albumin in patients with end-stage renal disease were lower than those of the general population (160.6 vs. 203.3 mg/dL, 48.5 vs. 59.7 mg/dL, and 3.7 vs. 4.4 g/dL, respectively). Mean levels of C-reactive protein were higher than those of the general population (3.80 vs. 1.16 mg/L). CONCLUSION: Hemodialysis patients have a high prevalence of cardiovascular risk factors and comorbidities. Levels of nutrition-related markers were lower, and C-reactive protein levels were higher, in hemodialysis patients than in the general population.


Subject(s)
Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Kidney Failure, Chronic/complications , Renal Dialysis/statistics & numerical data , Adult , Aged , Aged, 80 and over , C-Reactive Protein , Comorbidity , Cross-Sectional Studies , Female , Humans , Japan/epidemiology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Prevalence , Risk Factors , Surveys and Questionnaires
15.
Int J Urol ; 12(3): 305-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15828960

ABSTRACT

We report a case of a 31-year-old man with extrarenal angiomyolipoma of the perinephric space. He presented with asymptomatic macrohematuria. Computed tomography of the abdomen revealed a large perinephric mass which was separated from the right kidney and its unique growth appeared to have surrounded the kidney. Extrarenal angiomyolipomas of the perinephric fat are rare and they should be considered in the differential diagnosis of a retroperitoneal mass where asymptomatic macrohematuria was presented at the onset.


Subject(s)
Angiomyolipoma/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Retroperitoneal Neoplasms/diagnostic imaging , Adult , Angiomyolipoma/surgery , Humans , Kidney Neoplasms/surgery , Male , Nephrectomy , Retroperitoneal Neoplasms/surgery , Tomography, X-Ray Computed
16.
Nephron Clin Pract ; 98(3): c73-8, 2004.
Article in English | MEDLINE | ID: mdl-15528940

ABSTRACT

BACKGROUND: We determined the urinary levels of vascular endothelial growth factor (VEGF) in patients with reflux nephropathy to elucidate its clinical significance as a predictor of the development of renal damage. PATIENTS AND METHODS: Seventy-two patients (47 boys and 25 girls) aged 10-18 years with reflux nephropathy were studied. Vesicoureteral reflux was resolved surgically in all cases at least 2 years before enrollment. Urinary VEGF, alpha1-microglobulin and albumin levels were determined using morning spot urine samples. Plasma VEGF, serum creatinine and beta2-microglobulin levels were measured simultaneously. The severity of renal scarring and right and left kidney function were assessed by 99mTc dimercaptosuccinic acid renal scan. RESULTS: No significant correlation was found between the plasma and urinary VEGF levels. Urinary VEGF increased significantly with the increase in severity of renal scarring (p < 0.0001). Urinary VEGF levels correlated significantly with serum beta2-microglobulin (p < 0.002) and urinary alpha1-microglobulin (p < 0.03). No significant correlation of urinary VEGF levels with serum creatinine and urinary albumin levels was found. Nearly 60% of the patients with elevated urinary VEGF had normal levels of serum beta2-microglobulin and/or urinary alpha1-miocroglobulin. CONCLUSIONS: Urinary VEGF level appears to reflect its production in the kidney. Since urinary VEGF shows a propensity to elevate before the increase in serum beta2-microglobulin and/or urinary alpha1-microglobulin, urinary VEGF may serve as an early indicator of the development of reflux nephropathy.


Subject(s)
Vascular Endothelial Growth Factor A/urine , Vesico-Ureteral Reflux/urine , Adolescent , Albuminuria , Alpha-Globulins/urine , Child , Creatinine/blood , Female , Humans , Kidney/diagnostic imaging , Male , Radionuclide Imaging , Vascular Endothelial Growth Factor A/blood , Vesico-Ureteral Reflux/diagnostic imaging , beta 2-Microglobulin/blood
17.
J Urol ; 171(6 Pt 1): 2166-70, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15126778

ABSTRACT

PURPOSE: The development of renal cell carcinoma (RCC) is a critical problem in acquired renal cystic disease (ARCD) in patients with end stage renal disease, particularly males on chronic hemodialysis. We examined the expression of hepatcyte growth factor (HGF) and its receptor c-met in ARCD associated with RCC to elucidate the role of the HGF/c-met pathway in renal cyst development and subsequent tumor transformation. MATERIALS AND METHODS: Immunohistochemical expression of HGF, c-met and Bcl-2 was examined in 15 normal tissue samples of kidneys obtained from nephrectomy for localized RCC and 19 with ARCD associated with RCC from 16 patients on dialysis. The expression of HGF mRNA was examined by reverse transcriptase-polymerase chain reaction. RESULTS: In normal kidneys immunostaining for HGF was scarcely detected in renal tubular cells. Bcl-2 and c-met immunostaining was observed mainly in distal tubular cells. In nontumor areas of kidneys with ARCD associated RCC the expression of HGF and c-met was up-regulated in tubular and the cyst epithelial cells. Hyperplastic cysts with multilayer epithelium and micropapillary projection were the predominant cysts stained with HGF and c-met. Immunostaining for HGF and c-met was also detected in RCC regions. The Bcl-2 immunostaining pattern was similar to that of HGF and c-met in nontumor and RCC regions. On reverse transcriptase-polymerase chain reaction HGF mRNA expression was up-regulated in nontumor areas and RCC regions in ARCD. CONCLUSIONS: These results suggest that up-regulation of HGF and its receptor c-met may be involved in renal cyst formation and subsequent tumor transformation in patients with end stage renal disease. Increased Bcl-2 expression may promote this process through the inhibition of apoptosis.


Subject(s)
Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/metabolism , Hepatocyte Growth Factor/biosynthesis , Kidney Diseases, Cystic/complications , Kidney Diseases, Cystic/metabolism , Kidney Failure, Chronic/complications , Kidney Neoplasms/complications , Kidney Neoplasms/metabolism , Proto-Oncogene Proteins c-met/biosynthesis , Adult , Aged , Female , Humans , Immunohistochemistry , Kidney Diseases, Cystic/pathology , Male , Middle Aged
18.
Hinyokika Kiyo ; 50(2): 77-80, 2004 Feb.
Article in Japanese | MEDLINE | ID: mdl-15101160

ABSTRACT

We reported three cases (42, 20 and 18-year-old men) of advanced nonseminomatous testicular germ cell cancer treated by salvage high-dose chemotherapy (HDC) supported by peripheral blood stem cell autotransplantation. Two cases which had been refractory to (B) EP (bleomycin, etoposide, cisplatin) and VIP (etoposide, ifosfmide, cisplatin) chemotherapies received one course of high-dose CEI (carboplatin 1,250 mg/m2, etoposide 1,500 mg/m2 and ifosfamide 7.5 g/m2), and the other case had been refractory to PVB (cisplatin, vinblastine, bleomycin) and VIP chemotherapies received one course of high-dose CEI and high-dose CCT (carboplatin 800 mg/m2, cyclophosphamide 6 g/m2 and thiotepa 720 mg/m2). Only one case achieved an incomplete remission by HDC, which was verified as a pathological complete response at the following salvage surgery, and has been alive with no evidence of disease for 68 months. The others achieved no change of disease following HDC and died from cancer progression. Hepatotoxicity, neurotoxicity and severe depression occurred, but not fatal in 2 cases.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Germinoma/therapy , Salvage Therapy , Testicular Neoplasms/therapy , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Bleomycin/administration & dosage , Carboplatin/administration & dosage , Cisplatin/administration & dosage , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Etoposide/administration & dosage , Humans , Ifosfamide/administration & dosage , Male , Peripheral Blood Stem Cell Transplantation , Prognosis , Thiotepa/administration & dosage , Transplantation, Autologous , Vinblastine/administration & dosage
19.
J Urol ; 169(1): 309-12, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12478178

ABSTRACT

PURPOSE: We evaluate clinical characteristics of primary vesicoureteral reflux in infants in a multicenter study in Japan with special reference to the relation of renal parenchymal damage to urinary tract infection and gender. MATERIALS AND METHODS: Infants younger than 1 year old with primary vesicoureteral reflux were recruited from 14 hospitals during the 3-year registration period beginning in January 1996 and ending in December 1998. Various clinical parameters as well as renal parenchymal lesion on dimercaptosuccinic acid scintigraphy were evaluated. RESULTS: Of 356 infants enrolled 296 (83%) were male and 60 (17%) were female. In 85% of infants presenting symptom was febrile urinary tract infection. There were 204 bilateral (57%) and 152 unilateral (43%) cases. Reflux was bilateral in 56% of males versus 65% of females, and high grade (grades IV and V) in 58% of males versus 55% of females. Diffuse parenchymal lesion was similarly noted in infants with or without prior urinary tract infection (38% and 46%, respectively) and was more often noted in male than in female infants (42% versus 25%). CONCLUSIONS: Despite the current use of screening prenatal ultrasound, many infants are still diagnosed as having vesicoureteral reflux only after the occurrence of urinary tract infection. The greater severity of renal parenchymal lesion in male infants combined with similar incidence of diffuse parenchymal lesion in those with or without prior infection suggests preexisting congenital abnormalities in the male refluxing kidney.


Subject(s)
Vesico-Ureteral Reflux/congenital , Female , Humans , Infant , Infant, Newborn , Japan , Kidney/diagnostic imaging , Male , Radionuclide Imaging , Retrospective Studies , Urinary Tract Infections/etiology , Vesico-Ureteral Reflux/complications , Vesico-Ureteral Reflux/diagnosis , Vesico-Ureteral Reflux/diagnostic imaging
20.
Nephron ; 92(4): 812-6, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12399625

ABSTRACT

We determined urinary concentrations of alpha(1)-microglobulin and albumin in 155 patients with reflux nephropathy including 72 prepubertal (48 males and 24 females) and 83 postpubertal patients (43 males and 40 females) to elucidate the effect of age and gender in the progression of renal damage. Vesicoureteral reflux was resolved in all patients at least two years before enrollment into this study. Renal scarring was diagnosed with (99m)technetium dimercaptosuccinic acid renal scan. More severe renal scarring was found predominantly in male compared to female patients. Urinary alpha(1)-microglobulin levels were significantly lower in postpubertal female patients (mean +/- SD: 1.59 +/- 1.02 mg/g creatinine) than in prepubertal males and females (3.32 +/- 3.53 and 4.06 +/- 4, respectively; p < 0.007 and p < 0.002, respectively), and in postpubertal males (3.69 +/- 2.6; p < 0.002) regardless of severity of renal scarring. In the patients with severe unilateral renal scarring, urinary albumin levels were significantly higher in postpubertal males (81.9 +/- 239.5) than in prepubertal males and postpubertal females (25.8 +/- 63.1 and 13.8 +/- 7.7, respectively; p < 0.05 and p < 0.05, respectively). Our results suggest that glomerular injury may develop during adolescence predominantly in male patients with severe renal scarring. In contrast, renal damage indicated by urinary alpha(1)-microglobulon level appears to be ameliorated in female postpubertal patients. This gender difference may be attributed to sex hormones.


Subject(s)
Albuminuria , Alpha-Globulins/urine , Kidney Tubules/metabolism , Puberty , Vesico-Ureteral Reflux/pathology , Vesico-Ureteral Reflux/urine , Adolescent , Child , Female , Humans , Kidney Tubules/pathology , Male , Proteinuria , Sex Characteristics
SELECTION OF CITATIONS
SEARCH DETAIL
...